Immix Biopharma Inc. (IMMX)
NASDAQ: IMMX
· Real-Time Price · USD
2.39
0.04 (1.70%)
At close: Jun 16, 2025, 3:59 PM
2.25
-5.86%
After-hours: Jun 16, 2025, 06:11 PM EDT
1.70% (1D)
| Bid | 2.2 |
| Market Cap | 66.63M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -20.9M |
| EPS (ttm) | -0.71 |
| PE Ratio (ttm) | -3.37 |
| Forward PE | -3.09 |
| Analyst | Buy |
| Ask | 2.47 |
| Volume | 40,335 |
| Avg. Volume (20D) | 205,552 |
| Open | 2.37 |
| Previous Close | 2.35 |
| Day's Range | 2.33 - 2.40 |
| 52-Week Range | 1.26 - 3.00 |
| Beta | 0.30 |
About IMMX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMMX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMMX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+15.31%
IMMX stock has given up its prior gain. Immix Biop...
Unlock content with
Pro Subscription
3 weeks ago
+15.31%
Immix Biopharma shares are trading higher after the company announced the publication of cell therapy NXC-201 Abstract #7508, selected for oral presentation at the 2025 American Society of Clinical Oncology Annual Meeting.
